CSBR
CHAMPIONS ONCOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$5.15
+1.28%Margins
Gross margin
49.3%
EBITDA margin
0.7%
EBIT margin
-1.7%
Net margin
-1.9%
FCF margin
-10.1%
-29.2%
Return on equity
-3.4%
Return on assets
-7.0%
Return on invested capital
2.01x
Asset turnover
-$5.6M
Cash from operations
$0.31
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jul 1, 2026